Development of new ReaScan Mobile tests
Duration12/2023 - 12/2025 Total Budget498 520 € EU fundig228 960 € Our...
Read more Development of new ReaScan Mobile testsDuration12/2023 - 12/2025 Total Budget498 520 € EU fundig228 960 € Our...
Read more Development of new ReaScan Mobile testsECCMID is now ESCMID Global 2024. At the end of this month, Barcelona and ESCMID Global 2024 are...
Read more ESCMID Global 2024Reagena is participating in International Symposium on Tick-Borne Pathogens and Disease in Vienna,...
Read more ITPD 2023Reagena is attending the 10th European Meeting on Viral Zoonoses in St Raphaël, France 23 –...
Read more 10th European Meeting on Viral ZoonosesReagena is participating in ECCMID (European Congress of Clinical Microbiology & Infectious...
Read more Meet us at ECCMID 2023Reagena has been identified as best in class in the European zoonoticpoint-of-care diagnostic...
Read more Reagena Receives The 2023 Customer Value Leadership AwardReagena is attending International Conference on Lyme Borreliosis and other Tick-borne...
Read more ICLB 2022Reagena exhibits at Medica 2022 in Düsseldorf, Germany on November 14 - 17. We invite you to...
Read more Medica 2022Reagena offers EIA and rapid diagnostic kits for the tick transmitted diseases. If you wish to...
Read more AACC 2022We are attending ChemBio 2022 Helsinki Expo and Convention Centre 8th - 9th June.Come and meet us...
Read more ChemBio Finland 2022